U.S. Immunoassay Reagents and Device Market to 2032
Overview
The U.S. Immunoassay Reagents and Device Market is expected to reach a 10,592.22 USD Billion by 2032 and is projected to grow at a CAGR of 8.45% from 2025 to 2032.
U.S. Immunoassay Reagents and Device Market 2018-2032 USD Billion
U.S. Immunoassay Reagents and Device Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 7,297.65 USD Billion
- Projected Market Size (2032): 10,592.22 USD Billion
- CAGR (2025-2032): 8.45%
Key Findings of U.S. Immunoassay Reagents and Device Market
- The U.S. Immunoassay Reagents and Device Market was valued at 7,297.65 USD Billion in 2024.
- The U.S. Immunoassay Reagents and Device Market is likely to grow at a CAGR of 8.45% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Reagents & Kits in Product Segment accounted for the largest share of the market with a revenue of 4,541.81 USD Billion
- The fastest growing segment Chemiluminescence Immunoassays in Platform Segment grew Fastest with a CAGR of 10.69% during the forecast period from 2024 to 2032.
U.S. Immunoassay Reagents and Device Market Scope
- Analyzers
- Reagents & Kits
- Neonatal Screening
- Toxicology
- Autoimmune Disorders
- Other Applications
- Bone & Mineral Disorders
- Infectious Diseases
- Cardiology
- Hematology & Blood Screening
- Oncology and Endocrinology
- Others
- Blood Banks
- Research & Academic Laboratories
- Hospitals
- Clinical Laboratories
- Pharmaceutical And BioTechnique Companies
- Others
- Saliva
- Urine
- Blood
- Others
- Radioimmunoassays
- Chemiluminescence Immunoassays
- Fluorescence Immunoassays
- Enzyme Immunoassay
- Other Techniques
- Immuno-PCR
- Western Blotting
- Rapid Tests
- Enzyme-Linked Immunospot
- Enzyme-Linked Immunosorbent Assays
U.S. Immunoassay Reagents and Device Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2019 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 7,297.65 USD Billion |
| Market Value in 2032 | 10,592.22 USD Billion |
| CAGR (2025-2032) | 8.45% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Product,Application,End User,Specimen Type,Platform,Technique |
Regional Insights:
-
Leading Market (2024-2032): U.S., leading in terms of revenue 7,297.65 USD Billion in 2024
- Key Country: U.S., leading in terms of revenue with value of 7,297.65 USD Billion in 2024.
Segments and Scope
-
U.S. Immunoassay Reagents and Device Market to 2032, By Product
- Reagents & Kits is the largest segment in U.S. Immunoassay Reagents and Device Market to 2032 with a revenue of 4,541.81 USD Billion in the year 2024.
- Reagents & Kits is the Fastest growing segment in U.S. Immunoassay Reagents and Device Market to 2032 with a Growth rate of 8.79 % in forecast period 2025-2032.
-
U.S. Immunoassay Reagents and Device Market to 2032, By Application
- Oncology and Endocrinology is the largest segment in U.S. Immunoassay Reagents and Device Market to 2032 with a revenue of 1,930.91 USD Billion in the year 2024.
- Cardiology is the Fastest growing segment in U.S. Immunoassay Reagents and Device Market to 2032 with a Growth rate of 9.70 % in forecast period 2025-2032.
-
U.S. Immunoassay Reagents and Device Market to 2032, By End User
- Pharmaceutical And BioTechnique Companies is the largest segment in U.S. Immunoassay Reagents and Device Market to 2032 with a revenue of 2,326.16 USD Billion in the year 2024.
- Clinical Laboratories is the Fastest growing segment in U.S. Immunoassay Reagents and Device Market to 2032 with a Growth rate of 8.06 % in forecast period 2025-2032.
-
U.S. Immunoassay Reagents and Device Market to 2032, By Specimen Type
- Blood is the largest segment in U.S. Immunoassay Reagents and Device Market to 2032 with a revenue of 2,589.75 USD Billion in the year 2024.
- Saliva is the Fastest growing segment in U.S. Immunoassay Reagents and Device Market to 2032 with a Growth rate of 8.72 % in forecast period 2025-2032.
-
U.S. Immunoassay Reagents and Device Market to 2032, By Platform
- Enzyme Immunoassay is the largest segment in U.S. Immunoassay Reagents and Device Market to 2032 with a revenue of 2,391.41 USD Billion in the year 2024.
- Chemiluminescence Immunoassays is the Fastest growing segment in U.S. Immunoassay Reagents and Device Market to 2032 with a Growth rate of 8.61 % in forecast period 2025-2032.
-
U.S. Immunoassay Reagents and Device Market to 2032, By Technique
- Enzyme-Linked Immunosorbent Assays is the largest segment in U.S. Immunoassay Reagents and Device Market to 2032 with a revenue of 2,031.42 USD Billion in the year 2024.
- Enzyme-Linked Immunospot is the Fastest growing segment in U.S. Immunoassay Reagents and Device Market to 2032 with a Growth rate of 8.60 % in forecast period 2025-2032.
U.S. Immunoassay Reagents and Device Market Company Share Analysis
| Company Name |
|
||
| PerkinElmer Inc. | |||
| Thermo Fisher Scientific Inc. | |||
| Quidel Corporation | |||
| BIOMÉRIEUX | |||
| Bio-Rad Laboratories, Inc. | |||
U.S. Immunoassay Reagents and Device Market Geographical Sales Distribution, 2018-2032 USD Billion
U.S. Immunoassay Reagents and Device Market Company Profiling
Industry Related Reports
Frequently Asked Questions
Coming Soon....
U.S. Immunoassay Reagents and Device Market Scope
- Analyzers
- Reagents & Kits
- Neonatal Screening
- Toxicology
- Autoimmune Disorders
- Other Applications
- Bone & Mineral Disorders
- Infectious Diseases
- Cardiology
- Hematology & Blood Screening
- Oncology and Endocrinology
- Others
- Blood Banks
- Research & Academic Laboratories
- Hospitals
- Clinical Laboratories
- Pharmaceutical And BioTechnique Companies
- Others
- Saliva
- Urine
- Blood
- Others
- Radioimmunoassays
- Chemiluminescence Immunoassays
- Fluorescence Immunoassays
- Enzyme Immunoassay
- Other Techniques
- Immuno-PCR
- Western Blotting
- Rapid Tests
- Enzyme-Linked Immunospot
- Enzyme-Linked Immunosorbent Assays
Frequently Asked Questions
U.S. Immunoassay Reagents and Device Market Company Profiling
Frequently Asked Questions
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.